Beautiful Virgin Islands

Tuesday, Jun 24, 2025

Dexamethasone can help save lives of very ill patients, British trial into low-cost drug finds

Dexamethasone can help save lives of very ill patients, British trial into low-cost drug finds

Researchers gave the anti-inflammatory drug to some 2,000 hospitalised patients. Dexamethasone reduced deaths by one-third for patients on ventilators and one-fifth among patients who were on supplemental oxygen

A low-cost and widely available drug has been found to reduce the death rate by one-third among most severe Covid-19 patients, according to trial data published on Tuesday.

Dexamethasone, a generic anti-inflammatory medication, was hailed as the first life-saving drug by the University of Oxford scientists leading the coronavirus treatment testing project named “RECOVERY”.

Scientists around the world are racing against the clock to find a treatment for Covid-19, the illness caused by the new coronavirus that has sickened over 8 million and killed more than 431,000 globally. There are currently no specific treatments or vaccines for the deadly virus.

The trial gave a low dose – 6 milligrams – of the steroid to 2,104 hospitalised patients for 10 days and results were compared with 4,321 patients who did not use the drug.

Dexamethasone reduced deaths by one-third for patients on ventilators and one-fifth among patients who were on supplemental oxygen, compared to those who only received usual care.

However, the drug showed no benefit to those who did not require respiratory support, which is generally to assist the more critical patients.

The findings were published through a statement on Tuesday. There was no mention of peer review.

The Oxford researchers said they are “now working to publish the full details as soon as possible”, but are calling for the drug to become the “standard of care” in patients requiring oxygen treatment.

“The survival benefit is clear and large in those patients who are sick enough to require oxygen treatment, so dexamethasone should now become standard of care in these patients,” said Peter Horby, a professor of emerging infectious diseases and global health at the University of Oxford and one of the chief investigators for the trial.

Martin Landray, a professor of medicine and epidemiology at Oxford and also one of the chief investigators, said that the results showed the drug is the “first treatment demonstrated to reduce mortality is one that is instantly available and affordable worldwide”.

“It’s going to be very hard for any drug really to replace this, given that for less than £50 [$63] you can treat eight patients and save a life,” Landray said in an online briefing.

Nick Cammack, Covid-19 therapeutics accelerator lead at UK-based research charity Wellcome Trust called for the drug to be used worldwide.

“Dexamethasone must now be rolled out and accessed by thousands of critically ill patients around the world. It is highly affordable, easy to make, can be scaled up quickly and only needs a small dosage. Any and every successful treatment against Covid-19 must be made available to everyone who needs it globally, regardless of their ability to pay,” Cammack said.

“Potentially preventing one death in every eight ventilated patients would be remarkable,” he said. “While this study suggests dexamethasone only benefits severe cases, countless lives will be saved globally.”

An antiviral drug, remdesivir, is also being used in the treatment of patients in some countries with the benefits of shortening treatment time but scientists have different views about its effectiveness.





Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
“You Have 12 Hours to Flee”: Israeli Threat Campaign Targets Surviving Iranian Officials
Macron and Merz: Europe must arm itself in an unstable world
Germany and Italy Under Pressure to Repatriate $245bn of Gold from US Vaults
Airlines Evaluate Flight Cancellations Amid Escalating US-Iran Tensions
Starmer Invites Innovators to Join Government Talent Scheme
UK Economy’s Strong Opening Quarter Shows Signs of Cooling
Harrods Seeks Court Order to Secure Al Fayed Estate for Victims
BA and Singapore Airlines Cancel Dubai Flights Amid Middle East Tensions
Trump Faces Backlash from MAGA Base Over Iran Strikes
Meta Bets $14 B on Alexandr Wang to Drive AI Ambitions
WATCH: Israeli forces show the aftermath of a massive airstrike at Iran's Isfahan nuclear site
FedEx Founder Fred Smith, ‘Heart and Soul’ of the Company, Dies at 80
Chinese Factories Shift Away from U.S. Amid Trump‑Era Tariffs
Pimco Seizes Opportunity in Japan’s Dislocated Bond Market
Labubu Doll Drives Pop Mart to Status as China’s Most Valuable Toy Maker
Global Coal Demand Defies Paris Accord Goals
We have new information and breaking details to share about what is shaping up to be a historic air campaign tonight
Six Massive Bombs Dropped on Fordow; Trump: 'A Historic Moment for the U.S., Israel, and the World'
Fordow: Deeply Buried Iranian Enrichment Site in U.S.–Israel Crosshairs
United States Conducts Precision Strikes on Iran’s Nuclear Sites
US strikes Iran nuclear sites, Trump says
Pakistan to nominate Trump for Nobel Peace Prize.
BBC Demands Perplexity AI Immediately Stop Using Its Content
Telegram Founder: I Will Leave My Fortune to Over 100 of My Children
Political Turmoil Resurfaces in Belgium Amid Economic Concerns
Fed policymakers divided on timing of interest rate cuts
Trump signals imminent agreement with Harvard University
Inheritance tax referendum alarms Swiss billionaire community
Japan cancels bilateral security meeting amid US defence demands
AI skeptic Emily Bender warns that ‘the emperor has no clothes’
Israel Confirms Assassination of Quds Force Commander in Tehran
16 Billion Login Credentials Leaked in Unprecedented Cybersecurity Breach
Senate hearing on who was 'really running' Biden White House kicks off
Iranian Military Officers Reportedly Seek Contact with Reza Pahlavi, Signal Intent to Defect
FBI and Senate Investigate Allegations of Chinese Plot to Influence the 2020 Election in Biden’s Favor Using Fake U.S. Driver’s Licenses
Vietnam Emerges as Luxury Yacht Destination for Ultra‑Rich
Plans to Sell Dutch Embassy in Bangkok Face Local Opposition
China's Iranian Oil Imports Face Disruption Amid Escalating Middle East Tensions
Trump's $5 Million 'Trump Card' Visa Program Draws Nearly 70,000 Applicants
DGCA Finds No Major Safety Concerns in Air India's Boeing 787 Fleet
Airlines Reroute Flights Amid Expanding Middle East Conflict Zones
Elon Musk's xAI Seeks $9.3 Billion in Funding Amid AI Expansion
Trump Demands Iran's Unconditional Surrender Amid Escalating Conflict
Israeli Airstrike Targets Iranian State TV in Central Tehran
President Trump is leaving the G7 summit early and has ordered the National Security Council to the Situation Room
Taiwan Imposes Export Ban on Chips to Huawei and SMIC
Israel has just announced plans to strike Tehran again, and in response, Trump has urged people to evacuate
Netanyahu Signals Potential Regime Change in Iran
Juncker Criticizes EU Inaction on Trump Tariffs
EU Proposes Ban on New Russian Gas Contracts
×